Introduction {#sec1-1}
============

Non-typhoid serovars of *Salmonella enterica* subspecies *enterica* and *Campylobacter* spp. are the most common etiological agents of bacterial food-borne diseases in Europe (EFSA and ECDC, 2016). Recently, Havelaar *et al*. ([@ref14]) estimated that approximately 6.2 million cases of human salmonellosis occur in the EU member states each year. The incidence rates of *Salmonella* infections are generally elaborated from culture-confirmed cases, which constitute only a small fraction of all cases occurring in a community (Mellou *et al.*, [@ref21]).

Even though over 2500 different serotypes of *S. enterica* are reported to date (Popoff and Le Minor, [@ref24]), most human infections are caused by few serotypes. *S.* Enteritidis and *S.* Typhimurium are among the serovars most frequently associated with human food-borne diseases in the EU, accounting for up to 68% of confirmed human cases identified at the serotype level (Graziani *et al*., [@ref12]). Poultry and poultry products, particularly eggs, have been identified as the main source of human *S.* Enteritidis infections, whereas human *S.* Typhimurium infections mainly originated from pigs (Pires *et al*., [@ref23]). In the last two decades, detection of *S.* Typhimurium and *S.* Typhimurium monophasic variant (*S.* 4,\[5\],12:i-) characterized by antimicrobial resistance to Ampicillin (A), Streptomycin (S), Sulphonamide (Su), Tetracycline (T) (R-type ASSuT) and Chloramphenicol (C) (R-type ACSSuT) increased significantly in many countries (Capuano *et al*., [@ref3]; Lucarelli *et al*., [@ref18]).

The main epidemiological surveillance tools of salmonellosis carried out in the national reference laboratories remain the serotyping of isolates and the evaluation of their antibiotic resistance. Further and complementary data can be acquired from DNA fingerprinting, phage-typing and other molecular biology-based assays for *Salmonella* (Abatcha *et al*., [@ref1]).

In addition, serotype and antibiotic resistance of *Salmonella* strains are carried out by the use of well standardized techniques, whereas the evaluation of virulence markers is not standardized and universally accepted, though many assays have been developed over the years (Huehn *et al*., [@ref17]).

The aim of this study was to investigate serotype, antimicrobial susceptibility and virulotype of clinical non-typhoidal *S. enterica* strains, isolated from human samples in central and southern Italy.

Materials and Methods {#sec1-2}
=====================

One hundred and fifty *Salmonelle enterica* strains of human origin were collected from January 2013 to December 2015 by the *Centro Tipizzazione Salmonelle*, the public reference laboratory for *Salmonella* characterization, from hospitals located in Campania and Lazio regions (southern and central Italy). The isolates were serotyped and the antimicrobial susceptibility was performed on all isolates as below described; furthermore all *Salmonella* strains were molecularly characterized. All strains were isolated from hospitalized patients, whose ages ranged from 3 months to 81 years. In particular, 58 strains were isolated from children aged less than 5 years, 37 from patients aged between 5 and 15 year and 55 strains were isolated from adults. One hundred forty nine strains were isolated from stool samples, whereas 1 strain was isolated from lymphoid tissue (popliteal lymph node).

Isolates were serotyped by agglutination with specific sera (Statens Serum Institute, DK and Difco, NJ, USA) to identify variants of the somatic (O) and flagellar (H) antigens, according to White- Kauffmann-Le Minor scheme (Grimont and Weill, [@ref13]; Popoff and Le Minor [@ref24]).

Molecular identification of S. enterica serotype 4,\[5\],12:i:- {#sec2-1}
---------------------------------------------------------------

The serological identification of *S. enterica* serotype 4,\[5\],12:i:- specific was confirmed by molecular targets amplified as previous described (Capuano *et al.*, [@ref3]).

The antibiotic susceptibility of the isolates was studied by Kirby-Bauer disk diffusion method according to the Clinical and Laboratory Standards Institute recommendations (CLSI 2008). Eleven different antimicrobial categories were tested: penicillins (ampicillin, 10 μg), penicillins+blactamase inihibitors (amoxicillin-clavulanic acid, 30 μg), non-extended (1^st^ generation) spectrum cephalosporins (cephalothin, 30 μg), extended-spectrum (3^rd^ generation) cephalosporins (cefotaxime, 30 μg; ceftazidime, 30 μg), phenicols (chloramphenicol, 30 μg), polymyxins (colistinsulphate, 10 μg), quinolones (nalidixic acid, 30 μg; ciprofloxacin, 5 μg; enrofloxacin, 10 μg), aminoglycosides (gentamicin, 10 μg; kanamycin, 30 μg; streptomycin, 10 μg), sulphonamides (sulphonamide, 300 μg), tetracyclines (tetracycline, 30 μg), and folate pathway inhibitors (trimethoprimsulfamethoxazole, 25 μg). *Escherichia coli* ATCC 29213 was used as a quality control. Strains showing non-susceptibility to at least 1 antibiotic in 3 or more antimicrobial categories was defined as multidrug resistant (MDR) (Magiorakos *et al.*, [@ref19]).

In relation to virulotyping analysis, the isolates were analysed for the presence of 14 virulence genes: *invA, spvC* (Chiu and Ou, [@ref5]), *nanH*, *gipA*, *gtgB* (Mikasovà *et al.*, [@ref22]), *sodC1*, *mig5*, *srgA*, *sspH1*, *sspH2*, *rck* (Borriello *et al*., 2012), *pefA* (Heithoff *et al*., [@ref15]), *sopE* (Drahovska *et al.*, [@ref8]) and *grvA* (Ho and Slauch, [@ref16]), by singleplex, duplex or triplex PCR assays.

All *Salmonella* isolates were examined for the presence of 4 gene markers of the phage *P22* not related to *Salmonella* virulence: *eaE* (encoding for the Eae protein), *g8* (encoding for the phage scaffold protein), *g13* (encoding for holin) and *sieB* (encoding for the superinfection exclusion system) (Mikasova *et al.*, 2005).

All molecular assays were carried out in a reaction volume of 25 μL, employing 2 μL DNA template extracted from single *Salmonella* colonies through thermal cell lysis. Post-PCR detection of the amplicons was carried out by electrophoresis in agarose gel (1.5%) stained with SYBR-Safe (Life Technologies, Foster City, CA, USA).

Statistically significant differences in both the antibiotic resistance and virulotypes of the isolates were evaluated by the EpiInfo 7 software (Centers for Disease Control and Prevention, Atlanta, USA). A two-tailed chi-squared test (X^2^) was used to evaluate differences between proportions among the different stratification groups; variables with a value of P\<0.05 were considered statistically significant. The strength of the associations between data was quantified by computing the Odds Ratios (OR); OR values \>1, considering a 95% confidence interval, were accepted as significant.

Results {#sec1-3}
=======

Serotyping {#sec2-2}
----------

The 150 *S. enterica* strains studied belonged to 18 serotypes ([Table 1](#table001){ref-type="table"}); the most common were: *S*. Typhimurium (49/150), *S. Enteritidis* (40/150), *S.* 4,\[5\],12:i:- (37/150), and *S.* Napoli (7/150). These four serotypes accounted for 88.6% of all isolates. Other less frequent *Salmonella* serotypes were Derby, Poona, Rissen (2/150, 1.3%), and Agama, Blockley, Brandenburg, Bredeney, Edinburgh, Hadar, Irumu, Manhattan, Muenster, Nyborg, Ohio (1/150, 0.7%).

Antibiotic resistance {#sec2-3}
---------------------

Thirty-nine isolates (26.0%) out of 150 were susceptible to all antibiotics tested, whereas 12 (8.0%), 7 (4.6%) and 5 (3.3%) isolates were resistant to 1, 2 and 3 antibiotics, respectively. Interestingly, 86 isolates (57.3%) were resistant to 4 or more antibiotics, whereas 90/150 (60.0%) isolates were considered as MDR ([Table 1](#table001){ref-type="table"}). No strains showing non-susceptibility to all the antibiotics tested were found.

The majority of the isolates was resistant to tetracycline (64.0%), streptomycin (62.0%), sulphonamide (57.3%), and ampicillin (56.0%). Lower resistance rates were observed for nalidixic acid (23.3%), chloramphenicol (13.3%), amoxicillin-clavulanic acid (10.7%), trimethoprim-sulfametoxazole (8.0%), cephalothin (7.3%), enrofloxacin (2.7%), ceftazidime (2.0%), gentamcin (2.0%), ciprofloxacin (1.3%), colistin sulphate (1.3%), and cefotaxime (0.7%) .

[Table 2](#table002){ref-type="table"} show the clustering of the *Salmonella* isolates in 48 resistance patterns (R-type); sixty four strains showed the ASSuT R-type (38 ASSuT and 26 ASSuT plus other resistances) and 13 the ACSSuT R-type (1 ACSSuT and 12 ACSSuT plus other resistances).

The R-type ASSuT, frequently associated with the resistance to other antibiotics, was the most commonly detected profile (42.6%); in particular, the R-type ASSuT was observed in 63 out of the 86 *S. Typhimurium* and *S.* 4,\[5\],12:1:- isolates. Overall, the R-type ASSuT was commonly associated with resistance to nalidixic acid (23 isolates), rather than chloramphenicol (12 isolates).

Concerning the four *Salmonella* serotypes most commonly detected, *S*. Typhimurium showed 25 different R-types, *S*. Enteritidis 10, *S*. 4,\[5\],12:i:- 5, and *S.* Napoli 4, respectively.

Thirty-six out of the 37 *S*. 4,\[5\],12:i:- and 27 out of 49 *S.* Typhimurium strains showed the R-type ASSuT, in some cases associated to resistance to other antibiotics ([Table 1](#table001){ref-type="table"}).

Molecular characterization {#sec2-4}
--------------------------

[Table 3](#table003){ref-type="table"} reports the prevalence of virulence and phage marker genes in *Salmonella* strains found in the considered isolates, gene prevalence ranged from 0.66% to 100%.

Fifty six different virulence gene profiles were observed. The highly specific *Salmonella* gene marker *invA* was detected in all isolates, it was used as a confirmatory test of *Salmonella* detection. The virulence genes of bacteriophage origin *sspH2* (86.7%), *gtgB* (84.7%), *sodC1* (77.3%), *gipA* (60.0%), and *sspH1* (52.7%), were also frequently detected ([Table 3](#table003){ref-type="table"}).

In [Table 3](#table003){ref-type="table"} the plasmidic virulence genes found in our isolates are reported; the prevalence of these genes ranged from 4.7% to 34.0%: *srgA* (34.0%), *rck* (30.7%), *mig5* (30.0%), *pefA* (22.7%), and *spvC* (4.7%). Plasmidic virulence genes were not found in *Salmonella* serotypes Napoli and 4,\[5\],12:i:-.

A high variability was observed in the occurrence of specific virulence genes. Among the 56 virulotypes detected we found two predominant profiles (Table 4): 36 *invA, gipA, gtgB, sspH1, sspH2, sodC1* (19 *S.* 4,\[5\],12:i:- and 17 *S.* Typhimurium) and 21 *invA, gtgB, sopE, sspH2, sodC1, pefA, mig5, rck, srgA* (all *S.* Enteritidis).

The most commonly detected phage markers were *g8* (80.0%), *sieB* (17.3%), and *g13* (12.0%) ([Table 3](#table003){ref-type="table"}). Eleven different phage marker profiles were identified. The majority of the strains (57.3%) were positive for *g13* gene only: 31 4,\[5\],12:i:-, 27 *S.* Enteritidis, 25 *S.* Typhimurium, 1 *S.* Brandenburg, 1 *S.* Bredeney, and 1 *S.* Hadar.

Interestingly, all isolates *S*. Napoli was characterized by the absence of *g8* phage markers.

Discussion {#sec1-4}
==========

Serotyping {#sec2-5}
----------

In agreement with other authors (EFSA, 2016; Graziani *et al*., [@ref12]), this study showed that *S.* Typhimurium (32.7%, 49/150), *S.* Enteritidis (26.7%, 40/150) and *S.* 4,\[5\],12:i:- (24.7%, 37/150) were the most common serotypes responsible for human salmonellosis in Campania and Lazio regions ([Table 1](#table001){ref-type="table"}).

The frequent detection of *S.* Napoli (4.7%), although less common than *S.* Typhimurium, *S.* Enteritidis and *S.* 4,\[5\],12:i:- serotypes, is of some interest owing to its increasing relevance as human pathogen in Europe. Graziani *et al*. ([@ref12]) reported that in Italy, France and Switzerland from 2000 to 2011, the detection of *S*. Enteritidis and *S*. Infantis decreased significantly, S. Typhimurium remained stable, while other serotypes, including *S*. 4,\[5\],12:i:- and *S*. Napoli increased significantly. *S.* Napoli, however, is rarely isolated from livestock (Graziani *et al.*, [@ref10]) and it has never been recovered from foodstuffs of animal origin in southern Italy (Proroga *et al.*, [@ref25]), whereas its detection in several wild animals has been reported in Italy (wild boars Chiari *et al.*, [@ref4]; Zottola *et al.*, [@ref28]; wild birds Mancini *et al,.* [@ref20]).

Antibiotic resistance {#sec2-6}
---------------------

Twenty-six % of the isolates were susceptible to all the antibiotics tested. Among the top four serotypes analysed, *S.* Enteritidis (77.5%) and *S.* Napoli (57.2%) showed the lowest drug resistance, while *S.* Typhimurium and *S.* 4,\[5\],12:i:- displayed the highest number of resistances.

The resistance to the critically important antibiotics for human therapy, cefotaxime and ciprofloxacin, was very low, 0.6% and 1.3%, respectively; and none of the strains tested showed co-resistance to ciprofloxacin and cefotaxime. Furthermore frequent resistance to nalidixic acid was observed (23.3%), especially among *S.* Typhimurium strains (46.9%). In *S.* Typhimurium isolates, the R-type ASSuT was frequently (81%) associated to resistance to other antibiotics: nalidixic acid (51.3%), chloramphenicol (27 %), trimethoprim-sulphametoxazole (21.6%), amoxicillin-clavulanic acid (18.9%), cephalothin (13.5%), kanamycin (10.8%), enrofloxacin (8.1%), cephotaxime, ceftazidime, ciprofloxacin, gentamicin, colistin sulphate (2.7%). In *S.* 4,\[5\],12:i:- additional resistances to ASSUT R-type were rare (16.2%): 3 to nalidixic acid, 2 to amoxicillin- clavulanic acid, 1 to chloramphenicol, cephalothin and kanamicin, respectively. The R-type ASSuT associated with the resistance to chloramphenicol (R-type ACSSuT), which had a considerable impact on human health in the past, recently appears to be less frequent than R-type ASSuT with additional resistance to nalidixic acid (R-type ANaSSuT). ANaSSuT, in fact, is one of the most common R-types among the isolates analyzed in this study.

According to our data, the likelihood of recovering the ASSuT *Salmonella* R-type in human salmonellosis in the considered areas is significantly higher than non- ASSuT strains (*X^2^*=88.6).

In relation to virulotyping, as expected, the gene *invA* was detected in all the samples, irrespective of serotype.

None of the plasmid gene showed a prevalence higher than 34%. In agreement with the findings of Huehn *et al.* ([@ref17]) and Graziani *et al.* ([@ref11]), we did not find virulence plasmid genes in all *S.* Napoli and *S.* 4,5,12:i- isolates.

As reported by Rotger and Casadesús ([@ref26]), virulence plasmids were found only in a few serotypes of *Salmonella* ([Table 3](#table003){ref-type="table"}); although these two authors reported that all virulence plasmids share the *spv* gene, in our study the presence of plasmids related genes was not always associated to the presence of the *spvC* gene. This could mean that *Salmonella* can harbour more than one virulence plasmid. Genes related to bacterial virulence of phage origin (*gipA, gtgB, nanH, grvA, sopE, sspH1, sspH2* and *sodC1*) were unevenly detected among the tested serotypes. Among the four serotypes of more common detection, none of the phagic genes was missing in *S.* Typhimurium isolates, while 3 genetic elements (*nanH, grvA*, and *gtgE*) were never detected in *S.* Enteritidis and *S.* 4,\[5\],12:i:-. *S.* Napoli was the serotype with the lowest number of loci; indeed, only four out of the eight considered phagic genes were recovered from this serotype ([Table 3](#table003){ref-type="table"}).

A similar prevalence of *gtgB* (127/150) and *sspH2* (130/150) was detected in all isolates, while *nanH* (1/150) and *gtgE* (1/150) were found only in *S.* Typhimurium strains. *sodC1* (116/150) was detected in all most common serotypes, except *S.* Napoli.

Overall, 49 different virulence patterns were observed, 33 of which concerned the top 4 serovars. *S.* Typhimurium was the serotype that showed the greatest number of profiles for the virulence genes considered. It is noteworthy that the prevalent virulotype was identical in *S.* 4,\[5\],12:1:- and *S.* Typhimurium isolates (Table 4).

*S.* Typhimurium, *S.* Enteritidis and *S.* 4,\[5\],12:i:- showed marked homologies in virulotypes and drug resistance profiles, though *S.* Typhimurium displayed greater variability.

Phage markers {#sec2-7}
-------------

None of the *Salmonella* isolates analysed were positive for the presence of all these markers; in particular, 92, 28 and 8 isolates harboured 1, 2 and 3 markers, respectively. Twenty-two strains were devoid of phage markers. Isolates showed different positivity rates to the phage markers considered (*g8*, 80.0%; *sieB*, 17.3%; *g13* 12.0%; *eaC*, 5.3%). Serotype *S.* Napoli was found often positive (5/6) for *g13*. These 4 *loci* were associated in different ways, allowing the identification of 13 different profiles.

A strain of *S.* Typhimurium was characterized by the presence of the largest number of genes investigated (*invA*; *gipA*; *gtgB*; *grvA*; *sspH1*; *sspH2*; *sodC1*; *spvC*; *pefA*; *mig5*; *rcK*; *srgA*). Overall only in *S*. Typhimurium isolates all investigated genes were detected; indeed the *Salmonella* serotypes Enteritidis, 4,\[5\],12:i:- and Napoli were positive for *invA* and 14, 9 and 7, respectively, of all the loci analysed ([Table 3](#table003){ref-type="table"}).

Conclusions {#sec1-5}
===========

Although other and highly discriminating assays are today available, the use of these techniques provide useful information in studying the patterns of *Salmonella* infections. While many assays have been well standardized over the years (*e.g.* serotyping and antibiotic resistance), the detection of specific virulence and phage marker genes need further studies to make this technique fully comparable among different laboratories. Nonetheless, *Salmonella* virulotype recognition is a useful and promising approach for drawing up a panel of genes to use in epidemiological surveys and the combination of phenotypic and molecular assays has proved to be useful tools combination for epidemiological characterization of *Salmonella* isolates. The *S.* 4,\[5\],12:i:- serotype is usually reported as characterized by a single phenotypical profile; by contrast, in our study we identified 12 different profiles of this serotype. The increasing relevance of *S.* Napoli in Italy led to support its inclusion in the panel of strains to be considered in epidemiological studies.

The preliminary data from this study have considerable epidemiological implications. The combination of phenotypic and molecular assays for the characterization of *Salmonella* isolates proved to be helpful and relatively easy to implement.

The authors would like to thank Prof. Stefano Dumontet for his valuable suggestions.

###### 

Antimicrobial susceptibility patterns (ASSuT, ACSSuT, MDR and XDR) in *Salmonella enterica* strains.

  Serotype         No. (%)     Pan susceptible   MDR   ASSuT   ASSuT+others   ACSSuT   ACSSuT+others
  ---------------- ----------- ----------------- ----- ------- -------------- -------- ---------------
  Typhimurium      49 (32.7)   3                 42    7       20             1        9
  Enteritidis      40 (26.7)   31                2     0       0              0        0
  4,\[5\],12:i:0   37 (24.7)   0                 37    31      5              0        1
  Napoli           7 (4.7)     3                 0     0       0              0        0
  Derby            2 (1.3)     1                 0     0       0              0        0
  Poona            2 (1.3)     1                 0     0       0              0        0
  Rissen           2 (1.3)     0                 0     0       0              0        0
  Agama            1 (0.7)     0                 1     0       0              0        0
  Blockley         1 (0.7)     0                 1     0       0              0        0
  Brandenburg      1 (0.7)     0                 1     0       0              0        0
  Bredeney         1 (0.7)     0                 1     0       0              0        1
  Edinburgh        1 (0.7)     0                 1     0       0              0        0
  Hadar            1 (0.7)     0                 1     0       0              0        0
  Irumu            1 (0.7)     0                 1     0       1              0        0
  Manhattan        1 (0.7)     0                 1     0       0              0        0
  Muenster         1 (0.7)     0                 1     0       0              0        0
  Nyborg           1 (0.7)     0                 0     0       0              0        0
  Ohio             1 (0.7)     0                 0     0       0              0        1

Su: Sulphonamide; T: Tetracycline; S: Streptomycin; A: Ampicillin; C: Chloramphenicol; MDR: non-susceptibility to at least one agent in three or more antimicrobial categories.

###### 

Antibiotic resistance profiles in 150 *Salmonell*a strains of human origin.

  Prevalence, %   Resistance profiles
  --------------- --------------------------------------
  26.0            Pan susceptible
  25.3            A- S- Su- T
  10.0            A- S- Su- T- Na
  2.6             A- C- S- Su- T- Amc
  2.6             T
  2.0             Na
  1.3             S- Su- T- Na- Stx
  1.3             A- S- Su- T- Cf- Na
  1.3             S- Su- T
  1.3             A- S- Su- T- Amc
  1.3             S
  0.6             Cf
  0.6             Amc-K
  0.6             A
  0.6             T- Cip
  0.6             A- C- S- Amc- Cf
  0.6             A- C- S- Cf
  0.6             A- C- S- Su- T
  0.6             A- S- Su- T- Na- K- Stx
  0.6             A- S- Su- T- Na- Stx
  0.6             A- S- T- Amc- Cf- Na
  0.6             A- C- S- Su- T- Cf- Na
  0.6             A- S- Su- T- K
  0.6             A- C- S- Su- T- K- Stx
  0.6             A- C- S- Su- T- Stx
  0.6             A- S- Su- T- Stx
  0.6             A- S- Su- Amc
  0.6             A- C- S- Su- T- Amc- K
  0.6             A- S- Su- T- Ctx- Caz- Na
  0.6             C- S- Su- T
  0.6             C- S- T
  0.6             A- Su- T- Caz
  0.6             A- C- S- Su- T- Amc- Cu K- Stx
  0.6             A- C- S- Amc- Na- Cip- Enr- Cu K
  0.6             A- C- S- Su- T- Cf- K
  0.6             A- S- Su- T- Cf- Enr- K- Stx
  0.6             A- S- Su- T- Amc- Cf- Stx
  0.6             A- C- S- Su- T- Cf- Na- Enr- Stx- Cl
  0.6             S- T- Na
  0.6             S- T- Na- Enr
  0.6             S- T- Cf- Na- K- Cl
  0.6             S- Su
  0.6             T- Cip
  0.6             Su- T
  0.6             C- Na
  0.6             C- T- Na
  0.6             C- T
  0.6             Cu

A: Ampicillin; Amc: Amoxicillin-clavulanic acid; C: Chloramphenicol; Caz: Ceftazidime; Cip: Ciprofloxacine; Cl: Colistin sulphate; Cn: Gentamicin; Ctx: Cephotaxime; Enr: Enrofloxacin; K: Kanamycin; Kf: Cephalothin; Na: Nalidixic acid; S: Streptomycin; Su: Sulphonamide; Sxt: Trimethoprim-sulphametoxazole; T: Tetracycline.

###### 

Detection of virulence gene in Salmonella strains of human origin.

  Salmonella strain         Phage marker   Virulence gene of phage origin   Plasmidic virulence genes                                                                             
  ------------------- ----- -------------- -------------------------------- --------------------------- ---- ----- ---- ----- ---- ---- ---- ---- ----- ----- ---- ---- ---- ---- ----
  Typhimurium         49    49             6                                17                          7    47    41   46    1    4    11   36   46    43    5    4    8    8    13
  Enteritidis         40    40             2                                1                           \-   29    8    37    \-   \-   37   2    37    38    2    30   37   38   37
  4,\[5\],12:i:-      37    37             \-                               1                           1    33    37   36    \-   \-   14   28   33    33    \-   \-   \-   \-   \-
  Napoli              7     7              6                                1                           \-   \-    1    7     \-   \-   6    6    7     \-    \-   \-   \-   \-   \-
  Derby               2     2              1                                1                           \-   2     \-   \-    \-   \-   \-   \-   \-    \-    \-   \-   \-   \-   \-
  Poona               2     2              1                                1                           \-   1     \-   \-    \-   \-   1    \-   1     \-    \-   \-   \-   \-   1
  Rissen              2     2              \-                               2                           \-   2     \-   \-    \-   \-   \-   \-   1     \-    \-   \-   \-   \-   \-
  Agama               1     1              1                                1                           \-   1     1    \-    \-   \-   \-   \-   1     \-    \-   \-   \-   \-   \-
  Blockley            1     1              \-                               \-                          \-   \-    1    1     \-   \-   \-   1    1     1     \-   \-   \-   \-   \-
  Brandenburg         1     1              \-                               \-                          \-   1     \-   \-    \-   \-   \-   1    \-    \-    \-   \-   \-   \-   \-
  Bredeney            1     1              \-                               \-                          \-   1     \-   \-    \-   \-   \-   1    1     \-    \-   \-   \-   \-   \-
  Edinburgh           1     1              \-                               \-                          \-   \-    \-   \-    \-   \-   \-   \-   \-    \-    \-   \-   \-   \-   \-
  Hadar               1     1              \-                               \-                          \-   1     1    \-    \-   \-   \-   1    1     \-    \-   \-   \-   \-   \-
  Irumu               1     1              1                                \-                          \-   1     \-   \-    \-   \-   \-   \-   \-    1     \-   \-   \-   \-   \-
  Manhattan           1     1              \-                               \-                          \-   \-    \-   \-    \-   \-   \-   1    \-    \-    \-   \-   \-   \-   \-
  Muenster            1     1              \-                               \-                          \-   \-    \-   \-    \-   \-   \-   \-   \-    \-    \-   \-   \-   \-   \-
  Nyborg              1     1              \-                               \-                          \-   \-    \-   \-    \-   \-   \-   1    \-    \-    \-   \-   \-   \-   \-
  Ohio                1     1              \-                               1                           \-   1     \-   \-    \-   \-   \-   1    1     \-    \-   \-   \-   \-   \-
  All serotypes       150   150            18                               26                          8    120   90   127   1    4    69   79   130   116   7    34   45   46   51
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